Suven Life Sciences informs about outcome of board meeting

12 Aug 2020 Evaluate

Suven Life Sciences has informed that the Board of Directors of the company, at its meeting held on August 11, 2020, approved the following along with other business matters: took on record and approved the Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter ended 30th June, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Review Reports of the Statutory Auditors. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 15th September, 2020 to 17th September, 2020 for taking record of the Members of the Company for the purpose of 31st Annual General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

134.10 -9.20 (-6.42%)
21-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.10
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 875.10
Lupin 2140.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×